The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Animal Prescription Drugs Market Research Report 2025
Synopsis
Animal prescription drug is a prescription drug used to prevent, treat, diagnose, or purposefully regulate an animal's physiology. Animal prescription drugs mainly include: serum products, vaccines, diagnostic products, micro-ecological products, chemicals, antibiotics, biochemical drugs, radioactive drugs and external insecticides, disinfectants, etc.
The global Animal Prescription Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 141%.
This report aims to provide a comprehensive presentation of the global market for Animal Prescription Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Prescription Drugs.
Report Scope
The Animal Prescription Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Prescription Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Prescription Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco Animal Health
Ceva Sante Animale
MSD Animal Health
Zoetis
Virbac
Dechra
Vetoquinol
Animalcare Group
Ourofino Saude Animal
Boehringer Ingelheim
Segment by Type
Oral Type
Smear Type
Injection Type
Spray Type
Segment by Application
Companion Animal
Livestock Animal
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal Prescription Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal Prescription Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Animal prescription drug is a prescription drug used to prevent, treat, diagnose, or purposefully regulate an animal's physiology. Animal prescription drugs mainly include: serum products, vaccines, diagnostic products, micro-ecological products, chemicals, antibiotics, biochemical drugs, radioactive drugs and external insecticides, disinfectants, etc.
The global Animal Prescription Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 141%.
This report aims to provide a comprehensive presentation of the global market for Animal Prescription Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Prescription Drugs.
Report Scope
The Animal Prescription Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Prescription Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Prescription Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco Animal Health
Ceva Sante Animale
MSD Animal Health
Zoetis
Virbac
Dechra
Vetoquinol
Animalcare Group
Ourofino Saude Animal
Boehringer Ingelheim
Segment by Type
Oral Type
Smear Type
Injection Type
Spray Type
Segment by Application
Companion Animal
Livestock Animal
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal Prescription Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal Prescription Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Animal Prescription Drugs Market Overview
1.1 Product Overview and Scope of Animal Prescription Drugs
1.2 Animal Prescription Drugs Segment by Type
1.2.1 Global Animal Prescription Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral Type
1.2.3 Smear Type
1.2.4 Injection Type
1.2.5 Spray Type
1.3 Animal Prescription Drugs Segment by Application
1.3.1 Global Animal Prescription Drugs Market Value by Application: (2024-2030)
1.3.2 Companion Animal
1.3.3 Livestock Animal
1.4 Global Animal Prescription Drugs Market Size Estimates and Forecasts
1.4.1 Global Animal Prescription Drugs Revenue 2019-2030
1.4.2 Global Animal Prescription Drugs Sales 2019-2030
1.4.3 Global Animal Prescription Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Animal Prescription Drugs Market Competition by Manufacturers
2.1 Global Animal Prescription Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Animal Prescription Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Animal Prescription Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Animal Prescription Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Animal Prescription Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Animal Prescription Drugs, Product Type & Application
2.7 Animal Prescription Drugs Market Competitive Situation and Trends
2.7.1 Animal Prescription Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Animal Prescription Drugs Players Market Share by Revenue
2.7.3 Global Animal Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Animal Prescription Drugs Retrospective Market Scenario by Region
3.1 Global Animal Prescription Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Animal Prescription Drugs Global Animal Prescription Drugs Sales by Region: 2019-2030
3.2.1 Global Animal Prescription Drugs Sales by Region: 2019-2024
3.2.2 Global Animal Prescription Drugs Sales by Region: 2025-2030
3.3 Global Animal Prescription Drugs Global Animal Prescription Drugs Revenue by Region: 2019-2030
3.3.1 Global Animal Prescription Drugs Revenue by Region: 2019-2024
3.3.2 Global Animal Prescription Drugs Revenue by Region: 2025-2030
3.4 North America Animal Prescription Drugs Market Facts & Figures by Country
3.4.1 North America Animal Prescription Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Animal Prescription Drugs Sales by Country (2019-2030)
3.4.3 North America Animal Prescription Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Animal Prescription Drugs Market Facts & Figures by Country
3.5.1 Europe Animal Prescription Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Animal Prescription Drugs Sales by Country (2019-2030)
3.5.3 Europe Animal Prescription Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Animal Prescription Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Animal Prescription Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Animal Prescription Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Animal Prescription Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Animal Prescription Drugs Market Facts & Figures by Country
3.7.1 Latin America Animal Prescription Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Animal Prescription Drugs Sales by Country (2019-2030)
3.7.3 Latin America Animal Prescription Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Animal Prescription Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Animal Prescription Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Animal Prescription Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Animal Prescription Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Animal Prescription Drugs Sales by Type (2019-2030)
4.1.1 Global Animal Prescription Drugs Sales by Type (2019-2024)
4.1.2 Global Animal Prescription Drugs Sales by Type (2025-2030)
4.1.3 Global Animal Prescription Drugs Sales Market Share by Type (2019-2030)
4.2 Global Animal Prescription Drugs Revenue by Type (2019-2030)
4.2.1 Global Animal Prescription Drugs Revenue by Type (2019-2024)
4.2.2 Global Animal Prescription Drugs Revenue by Type (2025-2030)
4.2.3 Global Animal Prescription Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Animal Prescription Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Animal Prescription Drugs Sales by Application (2019-2030)
5.1.1 Global Animal Prescription Drugs Sales by Application (2019-2024)
5.1.2 Global Animal Prescription Drugs Sales by Application (2025-2030)
5.1.3 Global Animal Prescription Drugs Sales Market Share by Application (2019-2030)
5.2 Global Animal Prescription Drugs Revenue by Application (2019-2030)
5.2.1 Global Animal Prescription Drugs Revenue by Application (2019-2024)
5.2.2 Global Animal Prescription Drugs Revenue by Application (2025-2030)
5.2.3 Global Animal Prescription Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Animal Prescription Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Elanco Animal Health
6.1.1 Elanco Animal Health Corporation Information
6.1.2 Elanco Animal Health Description and Business Overview
6.1.3 Elanco Animal Health Animal Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Elanco Animal Health Animal Prescription Drugs Product Portfolio
6.1.5 Elanco Animal Health Recent Developments/Updates
6.2 Ceva Sante Animale
6.2.1 Ceva Sante Animale Corporation Information
6.2.2 Ceva Sante Animale Description and Business Overview
6.2.3 Ceva Sante Animale Animal Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ceva Sante Animale Animal Prescription Drugs Product Portfolio
6.2.5 Ceva Sante Animale Recent Developments/Updates
6.3 MSD Animal Health
6.3.1 MSD Animal Health Corporation Information
6.3.2 MSD Animal Health Description and Business Overview
6.3.3 MSD Animal Health Animal Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MSD Animal Health Animal Prescription Drugs Product Portfolio
6.3.5 MSD Animal Health Recent Developments/Updates
6.4 Zoetis
6.4.1 Zoetis Corporation Information
6.4.2 Zoetis Description and Business Overview
6.4.3 Zoetis Animal Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zoetis Animal Prescription Drugs Product Portfolio
6.4.5 Zoetis Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Animal Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Virbac Animal Prescription Drugs Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Dechra
6.6.1 Dechra Corporation Information
6.6.2 Dechra Description and Business Overview
6.6.3 Dechra Animal Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dechra Animal Prescription Drugs Product Portfolio
6.6.5 Dechra Recent Developments/Updates
6.7 Vetoquinol
6.6.1 Vetoquinol Corporation Information
6.6.2 Vetoquinol Description and Business Overview
6.6.3 Vetoquinol Animal Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Vetoquinol Animal Prescription Drugs Product Portfolio
6.7.5 Vetoquinol Recent Developments/Updates
6.8 Animalcare Group
6.8.1 Animalcare Group Corporation Information
6.8.2 Animalcare Group Description and Business Overview
6.8.3 Animalcare Group Animal Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Animalcare Group Animal Prescription Drugs Product Portfolio
6.8.5 Animalcare Group Recent Developments/Updates
6.9 Ourofino Saude Animal
6.9.1 Ourofino Saude Animal Corporation Information
6.9.2 Ourofino Saude Animal Description and Business Overview
6.9.3 Ourofino Saude Animal Animal Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ourofino Saude Animal Animal Prescription Drugs Product Portfolio
6.9.5 Ourofino Saude Animal Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Corporation Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Animal Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Boehringer Ingelheim Animal Prescription Drugs Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Animal Prescription Drugs Industry Chain Analysis
7.2 Animal Prescription Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Animal Prescription Drugs Production Mode & Process
7.4 Animal Prescription Drugs Sales and Marketing
7.4.1 Animal Prescription Drugs Sales Channels
7.4.2 Animal Prescription Drugs Distributors
7.5 Animal Prescription Drugs Customers
8 Animal Prescription Drugs Market Dynamics
8.1 Animal Prescription Drugs Industry Trends
8.2 Animal Prescription Drugs Market Drivers
8.3 Animal Prescription Drugs Market Challenges
8.4 Animal Prescription Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
